Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67

INTRODUCTION: Triple-negative breast cancer (TNBC), which is characterized by negativity for estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), is a high risk breast cancer that lacks specific targets for treatment selection. Chemotherapy is, therefore, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Shinichiro, Yashiro, Masakazu, Takashima, Tsutomu, Aomatsu, Naoki, Ikeda, Katsumi, Ogawa, Yoshinari, Ishikawa, Tetsuro, Hirakawa, Kosei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326564/
https://www.ncbi.nlm.nih.gov/pubmed/22126395
http://dx.doi.org/10.1186/bcr3068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326564/
https://www.ncbi.nlm.nih.gov/pubmed/22126395
http://dx.doi.org/10.1186/bcr3068

Ejemplares similares